Table 2. The main pharmacokinetic parameters of tramadol and O-desmethyl tramadol in group C and group D.
| Parameters | Tramadol | O-desmethyl tramadol | ||
|---|---|---|---|---|
| Group C | Group D | Group D | Group D | |
| AUC(0−t) (µg/L h) | 777.09 ± 232.62 | 1,647.49 ± 474.03** | 1,172.61 ± 170.75 | 1,226.57 ± 111.61 |
| AUC(0−∞) (µg/L h) | 790.48 ± 226.30 | 1,652.18 ± 474.39** | 1,175.84 ± 170.44 | 1,251.86 ± 103.71 |
| t1/2z (h) | 6.69 ± 5.14 | 2.74 ± 0.56 | 2.86 ± 0.71 | 4.06 ± 0.91* |
| Tmax (h) | 1.60 ± 0.55 | 0.90 ± 0.65 | 1.20 ± 0.45 | 0.90 ± 0.65 |
| Vz/F (L/kg) | 306.53 ± 308.69 | 51.44 ± 19.09 | 72.54 ± 25.45 | 94.72 ± 26.39 |
| CLz/F (L/h/kg) | 27.53 ± 9.92 | 12.81 ± 3.14** | 17.31 ± 2.60 | 16.07 ± 1.36 |
| Cmax (µg/L) | 245.83 ± 57.58 | 294.28 ± 85.18 | 292.40 ± 55.09 | 181.96 ± 65.78* |
Notes.
Group C: Tramadol single-use group; Group D: Tramadol with crizotinib (multiple dose for 7 days).
*P < 0.05, **P < 0.01, ***P < 0.001 in comparison with the control group.
- AUC
- area under the blood concentration–time curve
- t1/2z
- elimination half time
- Tmax
- peak time
- Vz/F
- apparent volume of distribution
- CLz/F
- blood clearance
- Cmax
- maximum blood concentration